New timing of chemo drugs may boost pancreatic cancer response
Disease control
Recruiting now
This study is testing whether changing the timing of two chemotherapy drugs, gemcitabine and nab-paclitaxel, can improve tumor shrinkage in people with pancreatic cancer that has spread to other organs. About 67 participants will receive the drugs on an optimized schedule. The go…
Phase: PHASE2 • Sponsor: Anne Noonan • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC